Myo, E. and Mohandas, C. 2025. Comparison of subcutaneous GLP-1 receptor agonists, semaglutide and dulaglutide, on HbA1c and weight loss outcomes: A systematic review. Advanced Journal of Professional Practice. 5, 1 (Jun. 2025), 45–46. DOI:https://doi.org/10.22024/UniKent/03/ajpp.1365.